MedTrace Logo

Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT.

NCT02920125 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2017-09-26

No results posted yet for this study

Summary

To evaluate the benefits of Ayurvedic SUVED \& REIMMUGEN Colostrum for reduction/reversal of symptoms and study clinical progress in Vascular disease; CAD, CAV, Stroke, DVT patients.

Conditions

  • Coronary Artery Disease
  • Cerebro Vascular Disease
  • Ischemic Heart Disease
  • Deep Vein Thrombosis
  • Peripheral Arterial Diseases
  • Vascular Disease

Interventions

DRUG

SUVED

Ayurvedic formulation in ghana (concentrated) in capsules; 500 mg each

COMBINATION_PRODUCT

REIMMUGEN

Whole Cow colostrum in powder put in capsules; 300mg each

OTHER

Grain flour placebo

Grain flour in capsules. Jowari flour in dummy Reimmugen and Ragi flour in dummy Suved placebos

Sponsors & Collaborators

  • Smt. Kashibai Navale Medical College and General Hospital

    collaborator OTHER

  • Health Solutions, India

    collaborator INDUSTRY

  • Sujata Vaidya

    lead INDUSTRY

Principal Investigators

  • Dr Shreepad M Bhat, MD · Smt Kashibai Navle Medical College & Gen Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-08-31
Completion
2017-09-30

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02920125 on ClinicalTrials.gov